AHCO · XBRL financial data
AdaptHealth financial statements, every quarter
The same tables from 12 filings, lined up. Matched by XBRL tag: renamed lines keep their history.
How these numbers work
- Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
- Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
- * marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
- 0 means a filing states zero; a dash (—) means no filing states that number.
- “year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
- Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
- Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
- Shares outstanding come from each filing's cover page, as of the date printed there.
- Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.
Income statement
CSVFiscal quarters (AHCO's year ends in late December)
| In millions of dollars | Dec 31, 2023 | Mar 31, 2024 | Jun 30, 2024 | Sep 30, 2024 | Dec 31, 2024 | Mar 31, 2025 | Jun 30, 2025 | Sep 30, 2025 | Dec 31, 2025 | Mar 31, 2026 | Jun 30, 2026 | Sep 30, 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue from contracts with customers | 858* | 792 | 806 | 806 | 857* | 778 | 800 | 820 | 846* | 820 | 740 | 746 |
| Cost of revenue | year only | — | — | — | year only | — | — | — | year only | — | — | — |
| Cost of goods and services sold | 698* | 676 | 679 | 682 | 543* | 657 | 646 | 658 | 674* | 708 | 636 | 631 |
| General and administrative | 47* | 48 | 57 | 49 | 205* | 87 | 97 | 90 | 108* | 96 | 96 | 89 |
| Operating income (loss) | (218)* | 51 | 52 | 63 | 98* | 23 | 79 | 62 | (73)* | 5 | (138) | (156) |
| Interest expense | 33* | 32 | 33 | 31 | 28* | — | — | — | year only | — | — | — |
| Other income (expense) | (23)* | (5) | 2 | 0 | 1* | 0 | 0 | 0 | (0)* | — | — | — |
| Income tax expense (benefit) | (18)* | 7 | 7 | 8 | 19* | 1 | 36 | 11 | 4* | (5) | (21) | (17) |
| Net income (loss) | (255)* | (2) | 19 | 23 | 50* | (7) | 15 | 25 | (103)* | (16) | (134) | (154) |
| Earnings per share, basic USD per share | (1.91)* | (0.02) | 0.13 | 0.16 | 0.37* | (0.05) | 0.10 | 0.17 | (0.76)* | (0.12) | (0.99) | (1.13) |
| Earnings per share, diluted USD per share | (1.95)* | (0.02) | 0.13 | 0.15 | 0.37* | (0.05) | 0.10 | 0.16 | — | (0.12) | (0.99) | (1.13) |
| Weighted average shares, basic millions of shares | 133* | 133 | 133 | 134 | 135* | 135 | 135 | 135 | 135* | 136 | 136 | 136 |
| Weighted average shares, diluted millions of shares | 131* | 133 | 136 | 137 | 137* | 135 | 137 | 137 | 132* | 136 | 136 | 136 |
Balance sheet
CSVFiscal quarters (AHCO's year ends in late December)
Cash flows
CSVFiscal quarters (AHCO's year ends in late December)
| In millions of dollars | Dec 31, 2023 | Mar 31, 2024 | Jun 30, 2024 | Sep 30, 2024 | Dec 31, 2024 | Mar 31, 2025 | Jun 30, 2025 | Sep 30, 2025 | Dec 31, 2025 | Mar 31, 2026 | Jun 30, 2026 | Sep 30, 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net income (loss) | (255)* | (2) | 19 | 23 | 50* | (7) | 15 | 25 | (103)* | (16) | (134) | (154) |
| Stock-based compensation | 5* | 5 | 5* | 1* | 4* | 5 | 6* | 5* | 5* | 7 | 6* | 1* |
| Depreciation and amortization | 92* | 93 | 91* | 91* | 91* | 94 | 92* | 98* | 98* | 106 | 120* | 117* |
| Net cash from operating activities | 155* | 49 | 198* | 144* | 150* | 96 | 162* | 161* | 183* | 94 | 145* | 157* |
| Purchases of property and equipment | 89* | 88 | 81* | 60* | 77* | 96 | 89* | 94* | 104* | 121 | 166* | 106* |
| Net cash from investing activities | (90)* | (88) | (81)* | (54)* | (87)* | (96) | 10* | (93)* | (124)* | (204) | (203)* | (108)* |
| Proceeds from issuing common stock | year only | — | — | — | — | — | — | — | — | — | — | — |
| Share repurchases | 20* | 0 | 0* | 0* | 0* | — | — | — | year only | — | — | — |
| Repayments of long-term debt | 20* | 25 | 120* | 228* | 50* | 25 | 150* | 50* | 25* | 14 | 411* | 330* |
| Net cash from financing activities | (44)* | 41 | (126)* | (60)* | (54)* | (56) | (157)* | (57)* | (33)* | 53 | 53* | (12)* |
| Net change in cash | 21* | 2 | (10)* | 30* | 10* | (56) | 15* | 12* | 26* | (58) | (5)* | 37* |
Compare with peers
SIC 8082 and related industry codes, similar size. Each row is the latest quarter reported.
How peers are chosen
- SIC 8082 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
- Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
- * marks a quarter worked out from the filing totals: for a 10-Q, the year-to-date total less the earlier one.
| Company | Cash ($M) | Revenue, quarter ($M) | Operating cash flow, quarter ($M) | Shares outstanding | Quarter |
|---|---|---|---|---|---|
| AdaptHealth | not reported | 746 | 157* | 136.5M | 10-QSep 30, 2026 |
| Addus HomeCare | 100 | 377 | 40* | 18.7M | 10-QJun 30, 2026 |
| Enhabit | 50 | 265 | 35 | 51.2M | 10-QMar 31, 2026 |
| BrightSpring Health Services | 718 | 4,213 | 204* | 199.0M | 10-QSep 30, 2026 |
| Aveanna Healthcare Holdings | 97 | 670 | 81* | 218.2M | 10-QJul 4, 2026 |
Not investment advice. Not affiliated with the U.S. SEC.